Cargando…

Predicted number of peanut‐allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance

Detalles Bibliográficos
Autores principales:	Remington, Benjamin C., Koppelman, Stef J., Green, Todd D., Lack, Gideon, Roberts, Graham, Campbell, Dianne E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291584/ https://www.ncbi.nlm.nih.gov/pubmed/34077581 http://dx.doi.org/10.1111/all.14973

Ejemplares similares

Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Efficacy of epicutaneous immunotherapy (EPIT) in a new model of peanut-induced eosinophilic esophagitis (EoE) and allergic enterpathy (AE)
por: Mondulet, Lucie, et al.
Publicado: (2011)

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities
por: Davis, Carla M., et al.
Publicado: (2022)

Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy
por: Bégin, Philippe, et al.
Publicado: (2021)

Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023)

Relevance of sensitization to legumes in peanut‐allergic children
por: Muller, Timé, et al.
Publicado: (2022)

Melatonin prevents allergic airway inflammation in epicutaneously sensitized mice
por: Liu, Xudong, et al.
Publicado: (2021)

Triclosan promotes epicutaneous sensitization to peanut in mice
por: Tobar, Steven, et al.
Publicado: (2016)

Biomarkers of severity and threshold of allergic reactions during oral peanut challenges
por: Santos, Alexandra F., et al.
Publicado: (2020)

Recent advances in epicutaneous immunotherapy and potential applications in food allergy
por: Hervé, Pierre-Louis, et al.
Publicado: (2023)

Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut
por: Santos, Alexandra F., et al.
Publicado: (2015)

Peanut components measured by ISAC: comparison with ImmunoCap and clinical relevance in peanut allergic children
por: Brand, H. K., et al.
Publicado: (2021)

The basophil activation test reflects the severity and the threshold of allergic reactions to peanut – a double-blind-placebo-controlled peanut challenge study
por: Santos, Alexandra, et al.
Publicado: (2015)

T cell specific and non specific tolerance mechanisms in peanut oil immunotherapy in peanut allergic subjects
por: Singh, Amit, et al.
Publicado: (2011)

Eliciting dose is associated with tolerance development in peanut and cow’s milk allergic children
por: Nitsche, C., et al.
Publicado: (2019)

Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
por: Senti, Gabriela, et al.
Publicado: (2013)

Innovative delivery systems for epicutaneous immunotherapy
por: Wang, Zhen, et al.
Publicado: (2023)

The relevance of oral food challenge in a patient allergic to peanut and tree nuts
por: Limão, Rita, et al.
Publicado: (2023)

Peanut thresholds in peanut‐allergic children are related to dietary composition
por: Luiten, Daisy, et al.
Publicado: (2023)

Peanut oral immunotherapy may improve health‐related quality of life among severe peanut allergic adolescents
por: Ödling, Maria, et al.
Publicado: (2023)

Home-Based Peanut Oral Immunotherapy for Low-Risk Peanut-Allergic Preschoolers During the COVID-19 Pandemic and Beyond
por: Chua, Gilbert T., et al.
Publicado: (2021)

Vitamin D levels in peanut allergic children
por: Fowlie, Adam, et al.
Publicado: (2011)

Induction of Allergic Responses to Peanut Allergen in Sheep
por: Van Gramberg, Jenna L., et al.
Publicado: (2012)

Risk Factors for Anaphylaxis in Children Allergic to Peanuts
por: Petek, Tadej, et al.
Publicado: (2023)

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
por: Dioszeghy, V, et al.
Publicado: (2014)

Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut
por: Dioszeghy, Vincent, et al.
Publicado: (2017)

Response to major peanut and peach allergens in a population of children allergic to peanut
por: Blanca, Miguel
Publicado: (2014)

Response to major peanut and peach allergens in a population of children allergic to peanut
por: Garcia-Blanca, Alexandra, et al.
Publicado: (2015)

Laser‐facilitated epicutaneous immunotherapy with hypoallergenic beta‐glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma
por: Korotchenko, Evgeniia, et al.
Publicado: (2020)

No difference in human mast cells derived from peanut allergic versus non‐allergic subjects
por: Larsen, Lau F., et al.
Publicado: (2018)

Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy
por: Wang, Yensheng, et al.
Publicado: (2021)

The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy
por: Liu, Guirong, et al.
Publicado: (2021)

Peanut sensitization in a group of allergic Egyptian children
por: Hossny, Elham, et al.
Publicado: (2011)

Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut‐sensitized mice
por: Mondoulet, L., et al.
Publicado: (2018)

Is peanut causing food allergy in Cuba? Preliminary assessment of allergic sensitization and IgE specificity profile to peanut allergens in Cuban allergic patients
por: Mateo-Morejón, Mayteé, et al.
Publicado: (2017)

Differences in Linear Epitopes of Ara h 9 Recognition in Peanut Allergic and Tolerant, Peach Allergic Patients
por: Sánchez-Ruano, L., et al.
Publicado: (2022)

Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses
por: Logan, Kirsty, et al.
Publicado: (2022)

Assessment of epicutaneous testing of a monovalent Influenza A (H1N1) 2009 vaccine in egg allergic patients
por: Pitt, Tracy, et al.
Publicado: (2011)

Epicutaneous Exposure to Staphylococcal Superantigen Enterotoxin B Enhances Allergic Lung Inflammation via an IL-17A Dependent Mechanism
por: Yu, Jinho, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k5qnrq683g8lij5lmilmj9ddtm